K-numberK242728
Device nameBeneVision Central Monitoring System
ApplicantShenzhen Mindray Bio-Medical Electronics Co., Ltd.
Product codeMSX
Device classClass II
Decision dateJul 31, 2025
DecisionSubstantially Equivalent
Regulation870.2300
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The BeneVision Central Monitoring System is a networked patient monitoring platform installed in healthcare facilities to provide clinicians remote real-time viewing, storage, and historical review of patient clinical data and alarms from compatible physiological monitors and anesthesia devices. It supports multiple network connections (Ethernet, WiFi, WMTS), telemetry systems, and includes the AlarmGUARD mobile application for alarm notifications to clinicians' devices.

Technological characteristics

Key changes from predicate K220058 include: Windows 11 support for CMS Viewer and Multi Patient Viewer; increased CPU cores and memory requirements across multiple modules; increased maximum WorkStation/ViewStation connections from 32 to 128 per CentralStation; support for Mindray anesthesia systems (A8, A9) with non-real-time data display and waveform accuracy; new AlarmGUARD feature for mobile alarm notifications; and separation of Multi Patient Viewer as an independent multi-instance component previously integrated with CMS Viewer.

Test standards cited

IEC 60601-2-27 (alarms in medical devices); IEC 60601-1-8 (alarms and alarm management); FDA guidance on Content of Premarket Submissions for Device Software Functions.

Substantial equivalence argument

Although the subject device expands compatibility to anesthesia systems and adds the AlarmGUARD mobile notification feature, the fundamental intended use—networked remote patient monitoring in healthcare facilities—remains identical to the predicate. Software enhancements (increased system capacity, Windows 11 support, multi-instance viewing) and anesthesia integration (non-real-time display only, no bi-directional control) do not raise new questions of safety or effectiveness. Software verification and validation testing, plus bench testing for AlarmGUARD compliance with IEC 60601-2-27 and human factors, confirm these changes maintain the same safety profile as the predicate device.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →